Insufficient scRNA-seq data for expression of UGT1A8 at single-cell level.
Insufficient scRNA-seq data for expression of UGT1A8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 1.00 | 1 / 1 |
bladder | 52% | 133.71 | 11 / 21 | 26% | 4.32 | 131 / 504 |
intestine | 43% | 111.47 | 415 / 966 | 26% | 0.60 | 135 / 527 |
esophagus | 15% | 7.15 | 221 / 1445 | 6% | 0.26 | 11 / 183 |
stomach | 0% | 0 | 0 / 359 | 12% | 0.38 | 35 / 286 |
kidney | 1% | 0.36 | 1 / 89 | 8% | 1.09 | 72 / 901 |
prostate | 7% | 7.59 | 17 / 245 | 2% | 0.23 | 9 / 502 |
lung | 0% | 0 | 0 / 578 | 9% | 1.17 | 99 / 1155 |
liver | 0% | 0 | 0 / 226 | 6% | 1.14 | 26 / 406 |
uterus | 0% | 0 | 0 / 170 | 6% | 1.19 | 28 / 459 |
pancreas | 0% | 0 | 0 / 328 | 6% | 0.30 | 10 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
adrenal gland | 0% | 0.21 | 1 / 258 | 0% | 0.02 | 1 / 230 |
breast | 0% | 0.73 | 1 / 459 | 0% | 0.00 | 2 / 1118 |
thymus | 0% | 0.03 | 1 / 653 | 0% | 0 | 0 / 605 |
skin | 0% | 0.02 | 2 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 0% | 0.03 | 1 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 0.01 | 2 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0009804 | Biological process | coumarin metabolic process |
GO_0052697 | Biological process | xenobiotic glucuronidation |
GO_0001889 | Biological process | liver development |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0045939 | Biological process | negative regulation of steroid metabolic process |
GO_0045922 | Biological process | negative regulation of fatty acid metabolic process |
GO_0051552 | Biological process | flavone metabolic process |
GO_0052696 | Biological process | flavonoid glucuronidation |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0008202 | Biological process | steroid metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0005504 | Molecular function | fatty acid binding |
GO_0001972 | Molecular function | retinoic acid binding |
GO_0005496 | Molecular function | steroid binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
Gene name | UGT1A8 |
Protein name | UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H) UDP-glucuronosyltransferase 1A8 UDP-glucuronosyltransferase (EC 2.4.1.17) |
Synonyms | GNT1 hCG_2039726 UGT1 |
Description | FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Catalyzes the glucuronidation of endogenous steroid hormones such as androgens and estrogens . Produces dihydrotestosterone (DHT) diglucuronide from the DHT after two subsequent glucoronidation steps . Also catalyzes the glucuronidation of the isoflavones genistein, daidzein, glycitein, formononetin, biochanin A and prunetin, which are phytoestrogens with anticancer and cardiovascular properties . Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist caderastan, a drug which can inhibit the effect of angiotensin II . Also metabolizes mycophenolate, an immunosuppressive agent . .; FUNCTION: [Isoform 2]: Lacks UGT glucuronidation activity but acts as a negative regulator of isoform 1. . |
Accessions | Q9HAW9 A9JQZ4 Q5DSZ6 A9JQZ1 A9JQZ2 ENST00000373450.5 [Q9HAW9-1] |